Search

everythinglearnresearchcommunity

for

Search:↓

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

Hirsutism is common body hair growth due to genetics and hormones, and while not a disease, it can be distressing; virilisation includes hirsutism with other male traits and needs medical attention.

The document concludes that women with PCOS need a comprehensive care model that covers reproductive, metabolic, and psychological health to improve their quality of life.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Myoinositol helps improve menstrual cycles and some skin issues in women with PCOS.

PCOS is a common hormonal disorder in women, often involving menstrual issues and increased diabetes risk, managed through lifestyle changes and targeted treatments.

Local testosterone treatment improved sexual desire in a female with fragile X syndrome.

PCOS is linked to diabetes and insulin resistance, and managing AGEs may help treat related symptoms.

The document concludes that accurate diagnosis and appropriate management are crucial for treating various hair disorders, which have significant psychological impacts.

Hormonal imbalances are a key cause of missed menstrual periods in women.

Herbal treatments can help manage PCOS symptoms.

More research is needed before using brown fat to treat polycystic ovary syndrome.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

PCOS requires personalized treatment to improve life quality and reduce health risks.

PCOS may increase the risk of certain cancers.

Hirsutism in teens is often due to polycystic ovarian syndrome and needs careful assessment and support.

Metformin helps manage weight, blood pressure, and hormonal imbalances in PCOS patients.

The document concludes that low-dose acne treatment is most suitable for moderate acne, with high patient satisfaction and low relapse rates.